Linda Higgins
Directeur/Membre du Conseil chez GALAPAGOS NV
Postes actifs de Linda Higgins
Sociétés | Poste | Début | Fin |
---|---|---|---|
GALAPAGOS NV | Directeur/Membre du Conseil | 22/10/2019 | - |
Independent Dir/Board Member | 22/10/2019 | 25/04/2023 | |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2010 | - |
ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/08/2021 | - |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Linda Higgins
Anciens postes connus de Linda Higgins
Sociétés | Poste | Début | Fin |
---|---|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Directeur Technique/Scientifique/R&D | - | - |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | 29/12/2010 | - |
Directeur des opérations | 16/09/2009 | 29/12/2010 | |
Directeur Technique/Scientifique/R&D | 01/01/2007 | 16/09/2009 | |
President | 11/05/2010 | 29/12/2010 |
Formation de Linda Higgins
Kenyon College | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Belgique | 2 |
Opérationnelle
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
GALAPAGOS NV | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Linda Higgins
- Expérience